Hematomyelia associated with coronavirus disease 2019: A rare case report

被引:0
作者
Zhang, Lin-Ming [1 ]
Zhang, Huan-Bo [2 ]
Fan, Fu-Rong [3 ]
Liu, Ming-Wei [3 ]
机构
[1] Kunming Med Univ, Affiliated Hosp 1, Dept Neurol, Kunming, Peoples R China
[2] Kunming Med Univ, Affiliated Hosp 1, Trauma Ctr, Kunming, Peoples R China
[3] Kunming Med Univ, Affiliated Hosp 1, Dept Emergency Med, 295 Xichang Rd, Kunming 650032, Peoples R China
关键词
case report; coronavirus disease 2019; hematomyelia; pulmonary infection; spinal cord injury; COVID-19;
D O I
10.1097/MD.0000000000034197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rationale:Coronavirus disease 2019 (COVID-19) can damage the central nervous system. Although there have been reports of cerebral hemorrhage and infarction caused by COVID-19, hematomyelia due to COVID-19 has never been reported. Patient concerns:A 40-year-old male was admitted to the hospital with positive nucleic acid detection for COVID-19 after experiencing fever for 2 weeks, urinary retention, fecal retention, and pain in both lower extremities for a week. Diagnoses:The patient diagnosis was established using thoracic and lumbar magnetic resonance imaging (MRI). Contrast-enhanced thoracic and lumbar MRI revealed subdural (dorsal predominant) short T1 and slightly long T2 bands in the T12-S2 infundibular canal in the scan field, and the subdural hematoma was yet to be distinguished from other diseases. Spinal cord edema was observed in the left vertebral plate and facet joint of the T11 vertebral body, indicative of inflammation. The cerebrospinal fluid (CSF) was positive for COVID-19 nucleic acid. Interventions:Antiinfection, immunomodulation, correction of acid-base balance and electrolyte disorders, improvement of circulation, nerve nutrition, and other symptomatic supportive treatments were administered to the patient. Outcomes:The patient symptoms significantly improved after 4 weeks of anti-infection and immunomodulatory therapy. Repeat thoracolumbar MRI revealed absorption of the spinal cord hematoma, and the patient was discharged from the hospital. To date, COVID-19-related hematomyelia has not been reported and anti-infective and immunomodulatory therapies may be effective. Lessons:COVID-19 not only easily leads to brain injury but can also cause spinal cord injury and even spinal cord hemorrhage. When patients with COVID-19 experience symptoms and signs of spinal cord injury, spinal cord injury and bleeding caused by COVID-19 should be considered, and MRI and lumbar puncture should be performed as soon as possible to make a clear diagnosis.
引用
收藏
页数:5
相关论文
共 15 条
[1]   Role of SARS-CoV-2 and ACE2 variations in COVID-19 [J].
Antony, Priya ;
Vijayan, Ranjit .
BIOMEDICAL JOURNAL, 2021, 44 (03) :235-244
[2]   Brain abnormalities in COVID-19 acute/subacute phase: A rapid systematic review [J].
Egbert, Anna Rita ;
Cankurtaran, Sadiye ;
Karpiak, Stephen .
BRAIN BEHAVIOR AND IMMUNITY, 2020, 89 :543-554
[3]   Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion [J].
Fumagalli, Valeria ;
Rava, Micol ;
Marotta, Davide ;
Di Lucia, Pietro ;
Laura, Chiara ;
Sala, Eleonora ;
Grillo, Marta ;
Bono, Elisa ;
Giustini, Leonardo ;
Perucchini, Chiara ;
Mainetti, Marta ;
Sessa, Alessandro ;
Garcia-Manteiga, Jose M. ;
Donnici, Lorena ;
Manganaro, Lara ;
Delbue, Serena ;
Broccoli, Vania ;
De Francesco, Raffaele ;
D'Adamo, Patrizia ;
Kuka, Mirela ;
Guidotti, Luca G. ;
Iannacone, Matteo .
SCIENCE IMMUNOLOGY, 2022, 7 (67)
[4]   Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) [J].
Harapan, Biyan Nathanael ;
Yoo, Hyeon Joo .
JOURNAL OF NEUROLOGY, 2021, 268 (09) :3059-3071
[5]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [J].
Huang, Chaolin ;
Wang, Yeming ;
Li, Xingwang ;
Ren, Lili ;
Zhao, Jianping ;
Hu, Yi ;
Zhang, Li ;
Fan, Guohui ;
Xu, Jiuyang ;
Gu, Xiaoying ;
Cheng, Zhenshun ;
Yu, Ting ;
Xia, Jiaan ;
Wei, Yuan ;
Wu, Wenjuan ;
Xie, Xuelei ;
Yin, Wen ;
Li, Hui ;
Liu, Min ;
Xiao, Yan ;
Gao, Hong ;
Guo, Li ;
Xie, Jungang ;
Wang, Guangfa ;
Jiang, Rongmeng ;
Gao, Zhancheng ;
Jin, Qi ;
Wang, Jianwei ;
Cao, Bin .
LANCET, 2020, 395 (10223) :497-506
[6]   Neuropathogenesis of SARS-CoV-2 infection [J].
Khan, Shumayila ;
Gomes, James .
ELIFE, 2020, 9 :1-9
[7]   COVID-19: A Global Threat to the Nervous System [J].
Koralnik, Igor J. ;
Tyler, Kenneth L. .
ANNALS OF NEUROLOGY, 2020, 88 (01) :1-11
[8]   Extra-respiratory manifestations of COVID-19 [J].
Lai, Chih-Cheng ;
Ko, Wen-Chien ;
Lee, Ping-Ing ;
Jean, Shio-Shin ;
Hsueh, Po-Ren .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (02)
[9]   Cerebrospinal fluid in COVID-19: A systematic review of the literature [J].
Lewis, Ariane ;
Frontera, Jennifer ;
Placantonakis, Dimitris G. ;
Lighter, Jennifer ;
Galetta, Steven ;
Balcer, Laura ;
Melmed, Kara R. .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 421
[10]   Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China [J].
Mao, Ling ;
Jin, Huijuan ;
Wang, Mengdie ;
Hu, Yu ;
Chen, Shengcai ;
He, Quanwei ;
Chang, Jiang ;
Hong, Candong ;
Zhou, Yifan ;
Wang, David ;
Miao, Xiaoping ;
Li, Yanan ;
Hu, Bo .
JAMA NEUROLOGY, 2020, 77 (06) :683-690